Clinical trial
Temozolomide and O6-Benzylguanine in Treating Children With Recurrent Brain…
NCT00052780 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00052780 |
|---|---|
| Title | Temozolomide and O6-Benzylguanine in Treating Children With Recurrent Brain Tumors |
| Official title | Phase I Trial of Temozolomide and O6-Benzylguanine in Pediatric Patients With Recurrent Brain Tumors |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Childhood Central Nervous System Germ Cell Tumor, Childhood Choroid Plexus Tumor, Childhood Craniopharyngioma, Childhood Ependymoblastoma, Childhood Grade I Meningioma, Childhood Grade II Meningioma, Childhood Grade III Meningioma, Childhood High-grade Cerebellar Astrocytoma, Childhood High-grade Cerebral Astrocytoma, Childhood Infratentorial Ependymoma and 15 more |
| Intervention type | Biological, Drug, Other |
| Interventions | O6-benzylguanine, temozolomide, filgrastim, pharmacological study, laboratory biomarker analysis |
| Enrollment | 72 |
| Start date | Oct 1, 2002 |
| Primary completion | Nov 1, 2007 |
| First posted | Jan 27, 2003 |
| Last update posted | Sep 30, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: